| Microbiome potentiates endurance exercise through intestinal acetate production T Okamoto, K Morino, S Ugi, F Nakagawa, M Lemecha, S Ida, N Ohashi, ... American Journal of Physiology-Endocrinology and Metabolism, 2019 | 172 | 2019 |
| MiR-494-3p regulates mitochondrial biogenesis and thermogenesis through PGC1-α signalling in beige adipocytes M Lemecha, K Morino, T Imamura, H Iwasaki, N Ohashi, S Ida, D Sato, ... Scientific reports 8 (1), 15096, 2018 | 81 | 2018 |
| Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: a … H Inoue, K Morino, S Ugi, S Tanaka‐Mizuno, K Fuse, I Miyazawa, ... Journal of diabetes investigation 10 (4), 1012-1021, 2019 | 56 | 2019 |
| Pivotal Role of O-GlcNAc Modification in Cold-Induced Thermogenesis by Brown Adipose Tissue Through Mitochondrial Biogenesis N Ohashi, K Morino, S Ida, O Sekine, M Lemecha, S Kume, SY Park, ... Diabetes 66 (9), 2351-2362, 2017 | 37 | 2017 |
| Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice S Ida, K Morino, O Sekine, N Ohashi, S Kume, T Chano, K Iwasaki, ... Diabetologia 60, 1761-1769, 2017 | 30 | 2017 |
| Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle K Murata, K Morino, S Ida, N Ohashi, M Lemecha, SY Park, A Ishikado, ... Biochemical and Biophysical Research Communications 495 (2), 2098-2104, 2018 | 22 | 2018 |
| A century-long journey from the discovery of insulin to the implantation of stem cell–derived islets A Ramzy, PJ Belmonte, MJS Braam, S Ida, EM Wilts, MK Levings, ... Endocrine Reviews 44 (2), 222-253, 2023 | 19 | 2023 |
| Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial K Horibe, K Morino, I Miyazawa, S Tanaka-Mizuno, K Kondo, D Sato, ... Diabetes research and clinical practice 186, 109781, 2022 | 18 | 2022 |
| Glycaemia and body weight are regulated by sodium-glucose cotransporter 1 (SGLT1) expression via O-GlcNAcylation in the intestine K Nishimura, Y Fujita, S Ida, T Yanagimachi, N Ohashi, K Nishi, A Nishida, ... Molecular Metabolism 59, 101458, 2022 | 9 | 2022 |
| Human A2-CAR T Cells Reject HLA-A2+ Human Islets Transplanted Into Mice Without Inducing Graft-versus-host Disease CE Ellis, M Mojibian, S Ida, VCW Fung, S Skovsø, E McIver, S O’Dwyer, ... Transplantation 107 (9), e222-e233, 2023 | 3 | 2023 |
| Protocol development to further differentiate and transition stem cell-derived pancreatic progenitors from a monolayer into endocrine cells in suspension culture MJS Braam, J Zhao, S Liang, S Ida, NK Kloostra, DG Iworima, M Tang, ... Scientific Reports 13 (1), 8877, 2023 | 3 | 2023 |
| O-linked N-acetylglucosamine modification is essential for physiological adipose expansion induced by high-fat feeding A Nakamoto, N Ohashi, L Sugawara, K Morino, S Ida, RJ Perry, I Sakuma, ... American Journal of Physiology-Endocrinology and Metabolism 325 (1), E46-E61, 2023 | 1 | 2023 |
| 307.2: bioprinted immune-protective islet-containing tissues successfully regulate blood glucose in rodent models of type 1 diabetes V Russo, R Jalili, S Pan, N Hakimi, R Agarwal, Y Yu, K Khan, K Jahan, ... Transplantation 105 (12S1), S23, 2021 | 1 | 2021 |
| Ipragliflozin, a SGLT2 Inhibitor, Reduced Body Weight and Fat Mass but Not Muscle Mass in Japanese Type 2 Diabetic Patients Treated with Insulin—A Randomized Clinical Trial K Morino, H Inoue, K Fuse, S Tanaka, K Kondo, H Arima, K Miura, D Sato, ... Diabetes 67 (Supplement_1), 2018 | 1 | 2018 |
| A case of leriche syndrome associated with acute diabetic muscle infarction subsequent to diabetic ketoacidosis D SATO, S IDA, T HONDA, S MAEKAWA, T NAKAMURA 糖尿病 55 (4), 269-273, 2012 | 1 | 2012 |
| 1501-P: Deletion of miR-494 Induces Adipocyte Browning and Slows Aging in Mice L SUGAWARA, K MORINO, H IWASAKI, S IDA, T YANAGIMACHI, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 816-P: Bioprinted Allogeneic Islet–Containing Implants Normalize Blood Glucose Control in Diabetic Rat Models without Immune Suppression V Russo, R Jalili, Y Yu, R Agarwal, S Pan, N Hakimi, K Jahan, EM Wilts, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 1713-P: Adipocyte O-GlcNAc Transferase Regulate Adipogenesis through De Novo Lipogenesis in Mice K Morino, A Tsuji, N Ohashi, S Ida, RJ Perry, S Ugi, Y Fujita, GI Shulman, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 1192-P: Dapagliflozin Reduces Intrahepatic Triglyceride Content in Japanese Patients with Type 2 Diabetes Treated with Oral Antidiabetic Agents: A Randomized, Clinical Trial K Morino, K Kondo, S Tanaka, I Miyazawa, K Fuse, S Ida, H Arima, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| Global and tissues-specific Ogt deletion revealed various effects of O-GlcNAcylation in glucose metabolism S Ida, K Morino, N Ohashi, O Sekine, S Kume, K Iwasaki, N Harada, ... DIABETOLOGIA 60, S115-S115, 2017 | | 2017 |
